Microbiology Spectrum-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2118914, encodeId=ebb2211891436, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：病毒 经验分享：投了4篇，中了1篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:57 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118913, encodeId=7c5121189136e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：微生物 经验分享：几个审稿人意见很专业，传染病领域比较优秀期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:25 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118725, encodeId=fbd32118e258d, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：一审87天，接到审稿意见后1天修回，3天后接收。主要是没找到合适的审稿人然后耽搁了，他找审稿人过程中，我连实验都提前补好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fba6418175, createdName=ms7000001520050986, createdTime=Fri Mar 10 22:15:54 CST 2023, time=2023-03-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114473, encodeId=b76121144e34c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：耐药性;生信分析 经验分享：美国微生物协会旗下AAC转投过来微生物谱，审稿意见是额外修改修后接受（大修），半个月内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4268537877, createdName=ms7000000696230758, createdTime=Mon Feb 13 20:44:01 CST 2023, time=2023-02-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2114162, encodeId=7d1c211416271, content=Under Evaluation快一个月了是啥情况啊？！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Sat Feb 11 22:30:05 CST 2023, time=2023-02-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=1234540, encodeId=fea912345400e, content=审稿速度:6.0 偏重的研究方向：宏基因组 经验分享：大修后小修不知道会不会被接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Mon Jul 25 08:33:15 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236708, encodeId=e35f1236e0881, content=偏重的研究方向：微生物学 经验分享：under peer review一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99cb6509389, createdName=ms3000000527868476, createdTime=Fri Aug 05 09:11:03 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090658, encodeId=49e7209065816, content=文章被接收后，收到发邮件“ This is to inform you that the submitting author has opted out for the Open Review Process for Microbiology Spectrum "，而且投稿系统也看不到原来我投的稿件了，大家有经历过吗？望大家不吝赐教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8d35274405, createdName=1482ce3am94暂无昵称, createdTime=Tue Sep 27 16:03:26 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238310, encodeId=05581238310c0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：耐药性;微生物学 经验分享：稿子太多了，疫情影响导致审稿人都不够用，投了两次都是35天直接退回，建议投其他杂志，原因也不说，真是气人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Fri Aug 12 16:46:15 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100024, encodeId=073721000244c, content=审稿速度:2.0 偏重的研究方向：微生物 经验分享：1.5月审稿，2个月修回，请教一下经验选手，修回命中概率大不？大概要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02dc2139313, createdName=**xxx, createdTime=Sat Nov 12 09:11:03 CST 2022, time=2022-11-12, status=1, ipAttribution=)]

2023-03-11 平凡之路来自河南省

审稿速度:3.0 | 投稿命中率:5.0
偏重的研究方向：病毒
经验分享：投了4篇，中了1篇

56 0

[GetPortalCommentsPageByObjectIdResponse(id=2118914, encodeId=ebb2211891436, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：病毒 经验分享：投了4篇，中了1篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:57 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118913, encodeId=7c5121189136e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：微生物 经验分享：几个审稿人意见很专业，传染病领域比较优秀期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:25 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118725, encodeId=fbd32118e258d, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：一审87天，接到审稿意见后1天修回，3天后接收。主要是没找到合适的审稿人然后耽搁了，他找审稿人过程中，我连实验都提前补好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fba6418175, createdName=ms7000001520050986, createdTime=Fri Mar 10 22:15:54 CST 2023, time=2023-03-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114473, encodeId=b76121144e34c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：耐药性;生信分析 经验分享：美国微生物协会旗下AAC转投过来微生物谱，审稿意见是额外修改修后接受（大修），半个月内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4268537877, createdName=ms7000000696230758, createdTime=Mon Feb 13 20:44:01 CST 2023, time=2023-02-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2114162, encodeId=7d1c211416271, content=Under Evaluation快一个月了是啥情况啊？！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Sat Feb 11 22:30:05 CST 2023, time=2023-02-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=1234540, encodeId=fea912345400e, content=审稿速度:6.0 偏重的研究方向：宏基因组 经验分享：大修后小修不知道会不会被接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Mon Jul 25 08:33:15 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236708, encodeId=e35f1236e0881, content=偏重的研究方向：微生物学 经验分享：under peer review一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99cb6509389, createdName=ms3000000527868476, createdTime=Fri Aug 05 09:11:03 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090658, encodeId=49e7209065816, content=文章被接收后，收到发邮件“ This is to inform you that the submitting author has opted out for the Open Review Process for Microbiology Spectrum "，而且投稿系统也看不到原来我投的稿件了，大家有经历过吗？望大家不吝赐教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8d35274405, createdName=1482ce3am94暂无昵称, createdTime=Tue Sep 27 16:03:26 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238310, encodeId=05581238310c0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：耐药性;微生物学 经验分享：稿子太多了，疫情影响导致审稿人都不够用，投了两次都是35天直接退回，建议投其他杂志，原因也不说，真是气人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Fri Aug 12 16:46:15 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100024, encodeId=073721000244c, content=审稿速度:2.0 偏重的研究方向：微生物 经验分享：1.5月审稿，2个月修回，请教一下经验选手，修回命中概率大不？大概要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02dc2139313, createdName=**xxx, createdTime=Sat Nov 12 09:11:03 CST 2022, time=2022-11-12, status=1, ipAttribution=)]

2023-03-11 平凡之路来自河南省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：微生物
经验分享：几个审稿人意见很专业，传染病领域比较优秀期刊

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2118914, encodeId=ebb2211891436, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：病毒 经验分享：投了4篇，中了1篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:57 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118913, encodeId=7c5121189136e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：微生物 经验分享：几个审稿人意见很专业，传染病领域比较优秀期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:25 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118725, encodeId=fbd32118e258d, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：一审87天，接到审稿意见后1天修回，3天后接收。主要是没找到合适的审稿人然后耽搁了，他找审稿人过程中，我连实验都提前补好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fba6418175, createdName=ms7000001520050986, createdTime=Fri Mar 10 22:15:54 CST 2023, time=2023-03-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114473, encodeId=b76121144e34c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：耐药性;生信分析 经验分享：美国微生物协会旗下AAC转投过来微生物谱，审稿意见是额外修改修后接受（大修），半个月内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4268537877, createdName=ms7000000696230758, createdTime=Mon Feb 13 20:44:01 CST 2023, time=2023-02-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2114162, encodeId=7d1c211416271, content=Under Evaluation快一个月了是啥情况啊？！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Sat Feb 11 22:30:05 CST 2023, time=2023-02-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=1234540, encodeId=fea912345400e, content=审稿速度:6.0 偏重的研究方向：宏基因组 经验分享：大修后小修不知道会不会被接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Mon Jul 25 08:33:15 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236708, encodeId=e35f1236e0881, content=偏重的研究方向：微生物学 经验分享：under peer review一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99cb6509389, createdName=ms3000000527868476, createdTime=Fri Aug 05 09:11:03 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090658, encodeId=49e7209065816, content=文章被接收后，收到发邮件“ This is to inform you that the submitting author has opted out for the Open Review Process for Microbiology Spectrum "，而且投稿系统也看不到原来我投的稿件了，大家有经历过吗？望大家不吝赐教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8d35274405, createdName=1482ce3am94暂无昵称, createdTime=Tue Sep 27 16:03:26 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238310, encodeId=05581238310c0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：耐药性;微生物学 经验分享：稿子太多了，疫情影响导致审稿人都不够用，投了两次都是35天直接退回，建议投其他杂志，原因也不说，真是气人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Fri Aug 12 16:46:15 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100024, encodeId=073721000244c, content=审稿速度:2.0 偏重的研究方向：微生物 经验分享：1.5月审稿，2个月修回，请教一下经验选手，修回命中概率大不？大概要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02dc2139313, createdName=**xxx, createdTime=Sat Nov 12 09:11:03 CST 2022, time=2022-11-12, status=1, ipAttribution=)]

2023-03-10 ms7000001520050986 来自湖北省

审稿速度:3.0 | 投稿命中率:95.0
经验分享：一审87天，接到审稿意见后1天修回，3天后接收。主要是没找到合适的审稿人然后耽搁了，他找审稿人过程中，我连实验都提前补好了

45 0

[GetPortalCommentsPageByObjectIdResponse(id=2118914, encodeId=ebb2211891436, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：病毒 经验分享：投了4篇，中了1篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:57 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118913, encodeId=7c5121189136e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：微生物 经验分享：几个审稿人意见很专业，传染病领域比较优秀期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:25 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118725, encodeId=fbd32118e258d, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：一审87天，接到审稿意见后1天修回，3天后接收。主要是没找到合适的审稿人然后耽搁了，他找审稿人过程中，我连实验都提前补好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fba6418175, createdName=ms7000001520050986, createdTime=Fri Mar 10 22:15:54 CST 2023, time=2023-03-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114473, encodeId=b76121144e34c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：耐药性;生信分析 经验分享：美国微生物协会旗下AAC转投过来微生物谱，审稿意见是额外修改修后接受（大修），半个月内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4268537877, createdName=ms7000000696230758, createdTime=Mon Feb 13 20:44:01 CST 2023, time=2023-02-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2114162, encodeId=7d1c211416271, content=Under Evaluation快一个月了是啥情况啊？！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Sat Feb 11 22:30:05 CST 2023, time=2023-02-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=1234540, encodeId=fea912345400e, content=审稿速度:6.0 偏重的研究方向：宏基因组 经验分享：大修后小修不知道会不会被接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Mon Jul 25 08:33:15 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236708, encodeId=e35f1236e0881, content=偏重的研究方向：微生物学 经验分享：under peer review一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99cb6509389, createdName=ms3000000527868476, createdTime=Fri Aug 05 09:11:03 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090658, encodeId=49e7209065816, content=文章被接收后，收到发邮件“ This is to inform you that the submitting author has opted out for the Open Review Process for Microbiology Spectrum "，而且投稿系统也看不到原来我投的稿件了，大家有经历过吗？望大家不吝赐教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8d35274405, createdName=1482ce3am94暂无昵称, createdTime=Tue Sep 27 16:03:26 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238310, encodeId=05581238310c0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：耐药性;微生物学 经验分享：稿子太多了，疫情影响导致审稿人都不够用，投了两次都是35天直接退回，建议投其他杂志，原因也不说，真是气人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Fri Aug 12 16:46:15 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100024, encodeId=073721000244c, content=审稿速度:2.0 偏重的研究方向：微生物 经验分享：1.5月审稿，2个月修回，请教一下经验选手，修回命中概率大不？大概要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02dc2139313, createdName=**xxx, createdTime=Sat Nov 12 09:11:03 CST 2022, time=2022-11-12, status=1, ipAttribution=)]

2023-02-13 ms7000000696230758 来自江苏省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：耐药性;生信分析
经验分享：美国微生物协会旗下AAC转投过来微生物谱，审稿意见是额外修改修后接受（大修），半个月内接受

48 0

[GetPortalCommentsPageByObjectIdResponse(id=2118914, encodeId=ebb2211891436, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：病毒 经验分享：投了4篇，中了1篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:57 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118913, encodeId=7c5121189136e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：微生物 经验分享：几个审稿人意见很专业，传染病领域比较优秀期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:25 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118725, encodeId=fbd32118e258d, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：一审87天，接到审稿意见后1天修回，3天后接收。主要是没找到合适的审稿人然后耽搁了，他找审稿人过程中，我连实验都提前补好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fba6418175, createdName=ms7000001520050986, createdTime=Fri Mar 10 22:15:54 CST 2023, time=2023-03-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114473, encodeId=b76121144e34c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：耐药性;生信分析 经验分享：美国微生物协会旗下AAC转投过来微生物谱，审稿意见是额外修改修后接受（大修），半个月内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4268537877, createdName=ms7000000696230758, createdTime=Mon Feb 13 20:44:01 CST 2023, time=2023-02-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2114162, encodeId=7d1c211416271, content=Under Evaluation快一个月了是啥情况啊？！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Sat Feb 11 22:30:05 CST 2023, time=2023-02-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=1234540, encodeId=fea912345400e, content=审稿速度:6.0 偏重的研究方向：宏基因组 经验分享：大修后小修不知道会不会被接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Mon Jul 25 08:33:15 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236708, encodeId=e35f1236e0881, content=偏重的研究方向：微生物学 经验分享：under peer review一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99cb6509389, createdName=ms3000000527868476, createdTime=Fri Aug 05 09:11:03 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090658, encodeId=49e7209065816, content=文章被接收后，收到发邮件“ This is to inform you that the submitting author has opted out for the Open Review Process for Microbiology Spectrum "，而且投稿系统也看不到原来我投的稿件了，大家有经历过吗？望大家不吝赐教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8d35274405, createdName=1482ce3am94暂无昵称, createdTime=Tue Sep 27 16:03:26 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238310, encodeId=05581238310c0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：耐药性;微生物学 经验分享：稿子太多了，疫情影响导致审稿人都不够用，投了两次都是35天直接退回，建议投其他杂志，原因也不说，真是气人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Fri Aug 12 16:46:15 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100024, encodeId=073721000244c, content=审稿速度:2.0 偏重的研究方向：微生物 经验分享：1.5月审稿，2个月修回，请教一下经验选手，修回命中概率大不？大概要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02dc2139313, createdName=**xxx, createdTime=Sat Nov 12 09:11:03 CST 2022, time=2022-11-12, status=1, ipAttribution=)]

2023-02-11 浩浩Peter 来自内蒙古

Under Evaluation快一个月了是啥情况啊？！

32 0

[GetPortalCommentsPageByObjectIdResponse(id=2118914, encodeId=ebb2211891436, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：病毒 经验分享：投了4篇，中了1篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:57 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118913, encodeId=7c5121189136e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：微生物 经验分享：几个审稿人意见很专业，传染病领域比较优秀期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:25 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118725, encodeId=fbd32118e258d, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：一审87天，接到审稿意见后1天修回，3天后接收。主要是没找到合适的审稿人然后耽搁了，他找审稿人过程中，我连实验都提前补好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fba6418175, createdName=ms7000001520050986, createdTime=Fri Mar 10 22:15:54 CST 2023, time=2023-03-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114473, encodeId=b76121144e34c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：耐药性;生信分析 经验分享：美国微生物协会旗下AAC转投过来微生物谱，审稿意见是额外修改修后接受（大修），半个月内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4268537877, createdName=ms7000000696230758, createdTime=Mon Feb 13 20:44:01 CST 2023, time=2023-02-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2114162, encodeId=7d1c211416271, content=Under Evaluation快一个月了是啥情况啊？！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Sat Feb 11 22:30:05 CST 2023, time=2023-02-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=1234540, encodeId=fea912345400e, content=审稿速度:6.0 偏重的研究方向：宏基因组 经验分享：大修后小修不知道会不会被接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Mon Jul 25 08:33:15 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236708, encodeId=e35f1236e0881, content=偏重的研究方向：微生物学 经验分享：under peer review一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99cb6509389, createdName=ms3000000527868476, createdTime=Fri Aug 05 09:11:03 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090658, encodeId=49e7209065816, content=文章被接收后，收到发邮件“ This is to inform you that the submitting author has opted out for the Open Review Process for Microbiology Spectrum "，而且投稿系统也看不到原来我投的稿件了，大家有经历过吗？望大家不吝赐教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8d35274405, createdName=1482ce3am94暂无昵称, createdTime=Tue Sep 27 16:03:26 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238310, encodeId=05581238310c0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：耐药性;微生物学 经验分享：稿子太多了，疫情影响导致审稿人都不够用，投了两次都是35天直接退回，建议投其他杂志，原因也不说，真是气人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Fri Aug 12 16:46:15 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100024, encodeId=073721000244c, content=审稿速度:2.0 偏重的研究方向：微生物 经验分享：1.5月审稿，2个月修回，请教一下经验选手，修回命中概率大不？大概要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02dc2139313, createdName=**xxx, createdTime=Sat Nov 12 09:11:03 CST 2022, time=2022-11-12, status=1, ipAttribution=)]

2022-07-25 ms3000000556942775

审稿速度:6.0
偏重的研究方向：宏基因组
经验分享：大修后小修不知道会不会被接受。。。

51 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118914, encodeId=ebb2211891436, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：病毒 经验分享：投了4篇，中了1篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:57 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118913, encodeId=7c5121189136e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：微生物 经验分享：几个审稿人意见很专业，传染病领域比较优秀期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:25 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118725, encodeId=fbd32118e258d, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：一审87天，接到审稿意见后1天修回，3天后接收。主要是没找到合适的审稿人然后耽搁了，他找审稿人过程中，我连实验都提前补好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fba6418175, createdName=ms7000001520050986, createdTime=Fri Mar 10 22:15:54 CST 2023, time=2023-03-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114473, encodeId=b76121144e34c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：耐药性;生信分析 经验分享：美国微生物协会旗下AAC转投过来微生物谱，审稿意见是额外修改修后接受（大修），半个月内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4268537877, createdName=ms7000000696230758, createdTime=Mon Feb 13 20:44:01 CST 2023, time=2023-02-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2114162, encodeId=7d1c211416271, content=Under Evaluation快一个月了是啥情况啊？！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Sat Feb 11 22:30:05 CST 2023, time=2023-02-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=1234540, encodeId=fea912345400e, content=审稿速度:6.0 偏重的研究方向：宏基因组 经验分享：大修后小修不知道会不会被接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Mon Jul 25 08:33:15 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236708, encodeId=e35f1236e0881, content=偏重的研究方向：微生物学 经验分享：under peer review一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99cb6509389, createdName=ms3000000527868476, createdTime=Fri Aug 05 09:11:03 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090658, encodeId=49e7209065816, content=文章被接收后，收到发邮件“ This is to inform you that the submitting author has opted out for the Open Review Process for Microbiology Spectrum "，而且投稿系统也看不到原来我投的稿件了，大家有经历过吗？望大家不吝赐教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8d35274405, createdName=1482ce3am94暂无昵称, createdTime=Tue Sep 27 16:03:26 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238310, encodeId=05581238310c0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：耐药性;微生物学 经验分享：稿子太多了，疫情影响导致审稿人都不够用，投了两次都是35天直接退回，建议投其他杂志，原因也不说，真是气人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Fri Aug 12 16:46:15 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100024, encodeId=073721000244c, content=审稿速度:2.0 偏重的研究方向：微生物 经验分享：1.5月审稿，2个月修回，请教一下经验选手，修回命中概率大不？大概要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02dc2139313, createdName=**xxx, createdTime=Sat Nov 12 09:11:03 CST 2022, time=2022-11-12, status=1, ipAttribution=)]

2022-08-05 ms3000000527868476

偏重的研究方向：微生物学
经验分享：under peer review一般多久呀

55 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118914, encodeId=ebb2211891436, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：病毒 经验分享：投了4篇，中了1篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:57 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118913, encodeId=7c5121189136e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：微生物 经验分享：几个审稿人意见很专业，传染病领域比较优秀期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:25 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118725, encodeId=fbd32118e258d, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：一审87天，接到审稿意见后1天修回，3天后接收。主要是没找到合适的审稿人然后耽搁了，他找审稿人过程中，我连实验都提前补好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fba6418175, createdName=ms7000001520050986, createdTime=Fri Mar 10 22:15:54 CST 2023, time=2023-03-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114473, encodeId=b76121144e34c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：耐药性;生信分析 经验分享：美国微生物协会旗下AAC转投过来微生物谱，审稿意见是额外修改修后接受（大修），半个月内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4268537877, createdName=ms7000000696230758, createdTime=Mon Feb 13 20:44:01 CST 2023, time=2023-02-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2114162, encodeId=7d1c211416271, content=Under Evaluation快一个月了是啥情况啊？！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Sat Feb 11 22:30:05 CST 2023, time=2023-02-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=1234540, encodeId=fea912345400e, content=审稿速度:6.0 偏重的研究方向：宏基因组 经验分享：大修后小修不知道会不会被接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Mon Jul 25 08:33:15 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236708, encodeId=e35f1236e0881, content=偏重的研究方向：微生物学 经验分享：under peer review一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99cb6509389, createdName=ms3000000527868476, createdTime=Fri Aug 05 09:11:03 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090658, encodeId=49e7209065816, content=文章被接收后，收到发邮件“ This is to inform you that the submitting author has opted out for the Open Review Process for Microbiology Spectrum "，而且投稿系统也看不到原来我投的稿件了，大家有经历过吗？望大家不吝赐教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8d35274405, createdName=1482ce3am94暂无昵称, createdTime=Tue Sep 27 16:03:26 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238310, encodeId=05581238310c0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：耐药性;微生物学 经验分享：稿子太多了，疫情影响导致审稿人都不够用，投了两次都是35天直接退回，建议投其他杂志，原因也不说，真是气人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Fri Aug 12 16:46:15 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100024, encodeId=073721000244c, content=审稿速度:2.0 偏重的研究方向：微生物 经验分享：1.5月审稿，2个月修回，请教一下经验选手，修回命中概率大不？大概要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02dc2139313, createdName=**xxx, createdTime=Sat Nov 12 09:11:03 CST 2022, time=2022-11-12, status=1, ipAttribution=)]

2022-09-27 1482ce3am94暂无昵称

文章被接收后，收到发邮件“ This is to inform you that the submitting author has opted out for the Open Review Process for Microbiology Spectrum "，而且投稿系统也看不到原来我投的稿件了，大家有经历过吗？望大家不吝赐教。

40 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118914, encodeId=ebb2211891436, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：病毒 经验分享：投了4篇，中了1篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:57 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118913, encodeId=7c5121189136e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：微生物 经验分享：几个审稿人意见很专业，传染病领域比较优秀期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:25 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118725, encodeId=fbd32118e258d, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：一审87天，接到审稿意见后1天修回，3天后接收。主要是没找到合适的审稿人然后耽搁了，他找审稿人过程中，我连实验都提前补好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fba6418175, createdName=ms7000001520050986, createdTime=Fri Mar 10 22:15:54 CST 2023, time=2023-03-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114473, encodeId=b76121144e34c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：耐药性;生信分析 经验分享：美国微生物协会旗下AAC转投过来微生物谱，审稿意见是额外修改修后接受（大修），半个月内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4268537877, createdName=ms7000000696230758, createdTime=Mon Feb 13 20:44:01 CST 2023, time=2023-02-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2114162, encodeId=7d1c211416271, content=Under Evaluation快一个月了是啥情况啊？！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Sat Feb 11 22:30:05 CST 2023, time=2023-02-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=1234540, encodeId=fea912345400e, content=审稿速度:6.0 偏重的研究方向：宏基因组 经验分享：大修后小修不知道会不会被接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Mon Jul 25 08:33:15 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236708, encodeId=e35f1236e0881, content=偏重的研究方向：微生物学 经验分享：under peer review一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99cb6509389, createdName=ms3000000527868476, createdTime=Fri Aug 05 09:11:03 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090658, encodeId=49e7209065816, content=文章被接收后，收到发邮件“ This is to inform you that the submitting author has opted out for the Open Review Process for Microbiology Spectrum "，而且投稿系统也看不到原来我投的稿件了，大家有经历过吗？望大家不吝赐教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8d35274405, createdName=1482ce3am94暂无昵称, createdTime=Tue Sep 27 16:03:26 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238310, encodeId=05581238310c0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：耐药性;微生物学 经验分享：稿子太多了，疫情影响导致审稿人都不够用，投了两次都是35天直接退回，建议投其他杂志，原因也不说，真是气人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Fri Aug 12 16:46:15 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100024, encodeId=073721000244c, content=审稿速度:2.0 偏重的研究方向：微生物 经验分享：1.5月审稿，2个月修回，请教一下经验选手，修回命中概率大不？大概要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02dc2139313, createdName=**xxx, createdTime=Sat Nov 12 09:11:03 CST 2022, time=2022-11-12, status=1, ipAttribution=)]

2022-08-12 可乐与红茶

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：耐药性;微生物学
经验分享：稿子太多了，疫情影响导致审稿人都不够用，投了两次都是35天直接退回，建议投其他杂志，原因也不说，真是气人

52 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118914, encodeId=ebb2211891436, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：病毒 经验分享：投了4篇，中了1篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:57 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118913, encodeId=7c5121189136e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：微生物 经验分享：几个审稿人意见很专业，传染病领域比较优秀期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb791638292, createdName=平凡之路, createdTime=Sat Mar 11 11:30:25 CST 2023, time=2023-03-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2118725, encodeId=fbd32118e258d, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：一审87天，接到审稿意见后1天修回，3天后接收。主要是没找到合适的审稿人然后耽搁了，他找审稿人过程中，我连实验都提前补好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fba6418175, createdName=ms7000001520050986, createdTime=Fri Mar 10 22:15:54 CST 2023, time=2023-03-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114473, encodeId=b76121144e34c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：耐药性;生信分析 经验分享：美国微生物协会旗下AAC转投过来微生物谱，审稿意见是额外修改修后接受（大修），半个月内接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4268537877, createdName=ms7000000696230758, createdTime=Mon Feb 13 20:44:01 CST 2023, time=2023-02-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2114162, encodeId=7d1c211416271, content=Under Evaluation快一个月了是啥情况啊？！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Sat Feb 11 22:30:05 CST 2023, time=2023-02-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=1234540, encodeId=fea912345400e, content=审稿速度:6.0 偏重的研究方向：宏基因组 经验分享：大修后小修不知道会不会被接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Mon Jul 25 08:33:15 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236708, encodeId=e35f1236e0881, content=偏重的研究方向：微生物学 经验分享：under peer review一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99cb6509389, createdName=ms3000000527868476, createdTime=Fri Aug 05 09:11:03 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090658, encodeId=49e7209065816, content=文章被接收后，收到发邮件“ This is to inform you that the submitting author has opted out for the Open Review Process for Microbiology Spectrum "，而且投稿系统也看不到原来我投的稿件了，大家有经历过吗？望大家不吝赐教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8d35274405, createdName=1482ce3am94暂无昵称, createdTime=Tue Sep 27 16:03:26 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238310, encodeId=05581238310c0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：耐药性;微生物学 经验分享：稿子太多了，疫情影响导致审稿人都不够用，投了两次都是35天直接退回，建议投其他杂志，原因也不说，真是气人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Fri Aug 12 16:46:15 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100024, encodeId=073721000244c, content=审稿速度:2.0 偏重的研究方向：微生物 经验分享：1.5月审稿，2个月修回，请教一下经验选手，修回命中概率大不？大概要等多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02dc2139313, createdName=**xxx, createdTime=Sat Nov 12 09:11:03 CST 2022, time=2022-11-12, status=1, ipAttribution=)]

2022-11-12 **xxx

审稿速度:2.0
偏重的研究方向：微生物
经验分享：1.5月审稿，2个月修回，请教一下经验选手，修回命中概率大不？大概要等多久？

32 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务